Effects of adrenergic blockade on the vasoconstrictor action of angiotensin in the perfused hind limb.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism*; D004285:Dogs; D005260:Female; D006614:Hindlimb / Q000098:blood supply; D008297:Male; D009411:Nerve Endings / Q000502:physiology*; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000502:physiology*; D014666:Vasomotor System / Q000502:physiology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D010643:Phenoxybenzamine; D000804:Angiotensin II; D011433:Propranolol